{
    "organizations": [],
    "uuid": "d620ae00e57ba8807895688c1f6e3ae4544eeb6c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/lonza-results/lonzas-fy-core-profit-soars-82-pct-on-acquisitions-idUSFWN1PP1JG",
    "ord_in_thread": 0,
    "title": "Lonza's FY core profit soars 82 pct on acquisitions",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "ZURICH, Jan 31 (Reuters) - Swiss drug ingredients maker Lonza reported on Wednesday a higher-than-expected 81 percent surge in its core 2017 profit, as the Basel-based company benefited from a slate of acquisitions.\nCore profit came in at 806 million Swiss francs ($864.53 million), higher than the 674 million franc average forecast of analysts in a Reuters poll. Companyâ€™s sales rose 23.5 percent to 5.1 billion francs, matching the 5.1 billion franc forecast in the poll. (Reporting by John Miller; Editing by Sherry Jacob-Phillips)\n ",
    "published": "2018-01-31T14:29:00.000+02:00",
    "crawled": "2018-02-01T14:59:32.026+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "zurich",
        "jan",
        "reuters",
        "swiss",
        "drug",
        "ingredient",
        "maker",
        "lonza",
        "reported",
        "wednesday",
        "percent",
        "surge",
        "core",
        "profit",
        "company",
        "benefited",
        "slate",
        "acquisition",
        "core",
        "profit",
        "came",
        "million",
        "swiss",
        "franc",
        "million",
        "higher",
        "million",
        "franc",
        "average",
        "forecast",
        "analyst",
        "reuters",
        "poll",
        "company",
        "sale",
        "rose",
        "percent",
        "billion",
        "franc",
        "matching",
        "billion",
        "franc",
        "forecast",
        "poll",
        "reporting",
        "john",
        "miller",
        "editing",
        "sherry"
    ]
}